IP Library › Granted Patent US 10,342,855
Granted Patent B2
US 10,342,855 · App. 16/056,366 · Granted Jul 9, 2019

Albumin-based non-covalent complexes and methods of use thereof

Inventors: Ravi Verma (Monrovia, CA); Changjun Yu (Pasadena, CA)
Assignee: Spectral Platforms, Inc.
A61K38/385A01N43/90A61K9/00C12Q1/04
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,342,855
App. No.
16/056,366
Granted
Jul 9, 2019
Kind
B2
Abstract

A non-covalent complex of an albumin molecule and a hydrophobic ligand, compositions containing the same, and methods of use thereof are provided. The present complex may find use in delivering the hydrophobic ligand to microorganisms that have albumin-binding outer surfaces, such as a cell wall.

Claims (26)

1. A method for determining the presence or absence of a microorganism in a sample, the method comprising:

i) contacting the sample with an aqueous solution comprising a plurality of non-covalent complexes, each non-covalent complex comprising a hydrophobic molecule and a single albumin protein, wherein the hydrophobic molecule is detectable and functionally associates with a microorganism when present in the sample;

ii) detecting one or more properties of the hydrophobic molecule; and

iii) determining that the microorganism is present or absent in the sample based on the detecting.

2. The method of claim 1 , wherein the hydrophobic molecule has one or more intermolecular distance-dependent properties, wherein the detecting comprises measuring in the sample one or more profiles of the one or more intermolecular distance-dependent properties, and wherein the determining comprises determining that the microorganism is present when the one or more profiles indicates the presence of aggregates of the hydrophobic molecule in the sample, or determining that the microorganism is absent when the one or more profiles indicates the absence of aggregates of the hydrophobic molecule in the sample.

3. The method of claim 1 , wherein the microorganism is a pathogenic microorganism.

4. The method of claim 2 , wherein the one or more intermolecular distance-dependent properties are one or more optical properties.

5. The method of claim 4 , wherein the one or more intermolecular distance-dependent properties comprise an optical absorption band and/or a Raman band.

6. The method of claim 4 , wherein the one or more intermolecular distance-dependent properties comprise Förster resonance energy.

7. The method of claim 1 , wherein the hydrophobic molecule is a carotenoid.

8. The method of claim 7 , wherein the carotenoid is a carotene.

9. The method of claim 8 , wherein the carotene is lycopene or β-carotene.

10. The method of claim 2 , wherein the one or more profiles comprises

a) a temporal profile at a fixed spatial point, and/or

b) a spatial profile at a fixed time point, of the height of Raman scattered light for the sample obtained by analyzing the sample with a spectrometer, and

wherein the determining comprises determining the presence or absence the microorganism in the sample based on the height of one of a plurality of characteristic Ramen peaks in the spatial profile, and/or the rate of change of one of the plurality of characteristic Raman peaks in the temporal profile, relative to a corresponding set of reference profiles.

11. The method of claim 1 , wherein the albumin protein is a human serum albumin protein.

12. The method of claim 1 , wherein detecting one or more properties of the hydrophobic molecule comprises

illuminating the sample with a broadband light source; and

collecting and analyzing with a spectrometer light transmitted through the sample, wherein a temporal profile at a fixed spatial point, or a spatial profile at a fixed time point, of the height of Raman and/or a UV-Vis absorption peak is analyzed, wherein

the height of one of a plurality of characteristic Raman and/or UV-vis peaks is used as an indicator when compared with a set of control values, or

the rate of change of one of the plurality of characteristic Raman peaks is used as an indicator, of the presence of the detectable hydrophobic molecule bound to the microorganism in the sample.

13. The method of claim 12 , wherein the microorganism is a pathogenic microorganism.

14. The method of claim 12 , wherein the hydrophobic molecule is a carotene.

15. The method of claim 14 , wherein the carotene is lycopene or β-carotene.

16. The method of any one of claim 12 , wherein the albumin protein is a human serum albumin protein.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 18, 2018
From: VERMA, RAVI; YU, CHANGJUN
To: SPECTRAL PLATFORMS, INC.
Reel/Frame 047104/0731 →
Continuity (4)
Division 15148587 · May 6, 2016
Provisional Application 62158670 · May 8, 2015
Provisional Application 62294931 · Feb 12, 2016
Related Publication 20190030135A1 · Jan 31, 2019
Cited By (1)
US 12,357,679